DBL Bortezomib bortezomib 1.0 mg powder for injection vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a45624bcb0dfe764
Product Name: DBL Bortezomib bortezomib 1.0 mg powder for injection vial
Artg Id: 313359
Artg Name: DBL Bortezomib bortezomib 1.0 mg powder for injection vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2020-02-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/fe875102a8261a47370231d511f3e10b.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8e2954d456fbe3e35ad4acde905ef547.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

a45624bcb0dfe764

Type

Standard